Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Mundipharma names Marc Princen as Global Chief Executive Officer

June 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …
Appointment

COVID-19: UK and Europe life sciences regulatory developments

June 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …
Feature

Tremfya’s skin clearance benefit lasts up to four years in plaque psoriasis patients, Janssen says

June 15, 2020 Research and Development, Sales and Marketing Janssen, Tremfya, plaque psoriasis

Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …
News

Fear of a coronavirus second wave as China reports highest number of cases in months

June 15, 2020 Sales and Marketing COVID, COVID-19, coronavirus, pandemic

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …
News

AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses

June 15, 2020 Sales and Marketing COVID, COVID-19, Vaccine, coronavirus

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …
News

NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer

June 15, 2020 Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …
News

AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients

June 15, 2020 Sales and Marketing AbbVie, leukaemia

AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …
News

Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million

June 12, 2020 Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …
News

Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes

June 12, 2020 Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …
News

Top Ten most popular articles on Pharmafile.com this week

June 12, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing coronavirus, top 10

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …
News

How digital therapeutics are revolutionising healthcare

June 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma

Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …
Feature

Ex-GSK exec named as Chief Medical Officer at Immatics Biotechnologies

June 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment, immatics

Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …
Appointment

Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents

June 10, 2020 Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma

Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …
News

EMA could approve Gilead’s streamlined remdesivir application for COVID-19 “within weeks”

June 9, 2020 Manufacturing and Production, Sales and Marketing COVID-19, EU, Gilead, coronavirus, remdesivir

The European Medicines Agency has received the application from Gilead for the first conditional marketing authorisation (CMA) of its antiviral …
News

AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients

June 8, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026